Skip to main content

Table 1 Demographic details of the patients with asthma across different COVID-19 severity groups

From: Pre-existing asthma as a comorbidity does not modify cytokine responses and severity of COVID-19

  Asthma with critical COVID-19 (n = 3) Asthma with severe COVID-19 (n = 10) Asthma with mild COVID-19 (n = 3)
Age 70 ± 11 56 ± 16 37 ± 17
BMI (kg/cm2) 27.52 ± 6.74 28.92 ± 4.63 26.94 ± 1.74
Gender (M/F) 3/0 7/3 1/2
Asthma severity (mild/severe) 3/0 10/0 3/0
Eosinophilic asthma 0 2 1
Blood eosinophil counts (cells/μL) 150 ± 36 210 ± 108 220 ± 0
PEF (L/min) 520 ± 0 500 ± 151 150 ± 0
FEV1 (L/min) NA 2.78 ± 1.28 NA
FEV1/FVC (%) NA 85.00 ± 4.24 NA
FeNO (ppb) NA NA NA
ICS Yes Yes Yes
OCS No No No
Biological treatments No No No
  1. BMI body mass index, FeNO fractional exhaled nitric oxide, FEV1 forced expiratory volume in one second, FVC forced vital capacity, ICS inhaled corticosteroids, OCS oral corticosteroids, PEF peak expiratory flow